Robert P. Driscoll
No más puestos en curso
Perfil
Prior to joining BioAdvance Mr. Driscoll was controller with BioRexis Pharmaceutical Corporation (acquired by Pfizer Corporation).
He also served as controller with Targeted Genetics Corporation (formerly Genovo, Inc.), and he held financial management positions with Nexell Therapeutics, Kulicke & Soffa Industries, Pfizer and ICI Americas.
Mr. Driscoll holds a Masters of Science in financial management and a Bachelor of Science in accounting from Drexel University.
Antiguos cargos conocidos de Robert P. Driscoll.
| Empresas | Cargo | Fin |
|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Corporate Officer/Principal | - |
Formación de Robert P. Driscoll.
| Drexel University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert P. Driscoll
